Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Cohort Study:Forecast Fracture Risk With a Serum Marker of Type 2 Diabetes in Guangzhou Community

NCT03456271 is registered in ClinicalTrials.gov with Zhujiang Hospital as lead sponsor.

NCT NCT03456271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03456271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Cohort Study:Forecast Fracture Risk With a Serum Marker of Type 2 Diabetes in Guangzhou Community
Lead sponsor
Zhujiang Hospital
Phase
Observational
Overall status
Terminated
Start date
July 1, 2017
Completion date
December 31, 2021
Enrollment
99 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus and fragility fractures